20161
- On August 1 2016 the company changed its name to Inspyr Therapeutics. (wikipedia.org)
Holdings1
- Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. (bazaartrend.com)
Company2
- Inspyr Therapeutics, Inc. (OTC: NSPX) is a development-stage pharmaceutical company based in San Antonio, Texas. (wikipedia.org)
- The company is focused on therapeutics that deliver a cancer-destroying drug directly to the tumor or its supporting environment, the tumor vasculature. (wikipedia.org)